NanoSpeed Diagnostics and Test4D™ achieves major sales milestone
EDMONTON, Alberta – NanoSpeed Diagnostics Inc. (“NanoSpeed” or “the Company”) is pleased to announce that Test4D™, the world’s first point-of-care test for vitamin D sufficiency, has reached sales of one million (1,000,000) tests since the product launch in 2013.
“The achievement of this milestone is both a demonstration of the strong demand for on-the-spot point of care testing, as well as the increasing recognition of the importance that vitamin D plays in our everyday health”, said Dr. Seema Gupta, President & CEO of NanoSpeed. “Sales continue to grow at a record pace year-over-year as distribution demands grow for a high quality and reliable test for vitamin D.”
Test4D™ is currently being sold through distributors globally based in Europe, China, India and the Philippines.
This sales milestone achievement represents record-breaking news for NanoSpeed. As the Company works to add new distributors and to develop new tests for commercialization with its partners, management continues to demonstrate a commitment to sustainable growth.
Dr. Seema Gupta continues, “As we celebrate this milestone, we have always believed it is important to thank our customers, distribution partners, employees, research and development collaborators and investors for their continued support. Additionally, we would like to thank TEC Edmonton and its Health Accelerator Program as well as our dedicated Executive-in-Residence for ongoing strategic counsel of our business development activities as we continue to grow and strengthen our company and brand.”
Test4D™ is not approved for commercial use in Canada or the United States and is limited by federal law to research or investigational use only.